Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

3.79
BATS BZX Real-Time Price
As of 1:38pm ET
 -0.22 / -5.49%
Today’s Change
2.45
Today|||52-Week Range
5.09
+24.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$397.5M

Company Description

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases. Its lead product candidate includes plecanatide a phase 3 guanylate cyclase C, or GC-C, receptor agonist, designed to treat GI disorders, primarily chronic idiopathic constipation, or CIC, and constipation-predominant irritable bowel syndrome, or IBS-C. CIC and IBS-C are functional gastrointestinal disorders that afflict millions of individuals worldwide. The company was founded by Kunwar Shailubhai on November 15, 2005 and is headquartered in New York, NY.

Contact Information

Synergy Pharmaceuticals, Inc.
420 Lexington Avenue
New York New York 10170
P:(212) 297-0020
Investor Relations:

Employees

Shareholders

Mutual fund holders13.67%
Other institutional12.55%
Individual stakeholders1.61%

Top Executives

Gary S. JacobChairman, President & Chief Executive Officer
Laura BarrowSenior Vice President-Clinical Operations
Bernard F. DenoyerSecretary, SVP-Finance & Head-Investor Relations
Kunwar ShailubhaiChief Scientific Officer
Patrick H. GriffinChief Medical Officer & Executive Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account